Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
Tuyển tập báo cáo các nghiên cứu khoa học quốc tế ngành y học dành cho các bạn tham khảo đề tài: Factors associated with premature mortality among young injection drug users in Vancouver | Harm Reduction Journal BioMed Central Open Access Factors associated with premature mortality among young injection drug users in Vancouver Cari L Miller 1 Thomas Kerr1 2 Steffanie A Strathdee1 3 Kathy Li1 and Evan Wood1 2 Address 1British Columbia Centre for Excellence in HIV AIDS St. Paul s Hospital Vancouver Canada 2University of British Columbia Department of Medicine Vancouver Canada and 3University of California at San Diego Division of International and Cross-Cultural Medicine San Diego USA Email Cari L Miller - cmiller@cfenet.ubc.ca Thomas Kerr - tkerr@cfenet.ubc.ca Steffanie A Strathdee - sstrathdee@ucsd.edu Kathy Li - kathyli@cfenet.ubc.ca Evan Wood - ewood@cfenet.ubc.ca Corresponding author Published 04 January 2007 Received 10 August 2006 Accepted 04 January 2007 Harm Reduction Journal 2007 4 1 doi l0.ll86 l477-75l7-4-l p This article is available from http www.harmreductionjournal.cOm content 4 l l 2007 Miller et al licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License http creativecommons.org licenses by 2.0 which permits unrestricted use distribution and reproduction in any medium provided the original work is properly cited. Abstract_ Background Young injection drug users IDUs may be at increased risk of premature mortality due to the health risks associated with injection drug use including overdoses and infections. However there has been little research conducted on mortality causes rates and associations among this population. We undertook this study to investigate patterns of premature mortality prior to age 30 years among young IDUs. Methods Since 1996 572 young 29 years IDUs have been enrolled in the Vancouver Injection Drug Users Study VIDUS . Semi-annually participants have completed an interviewer-administered questionnaire and have undergone serologic testing for HIV and hepatitis C
